North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

The North America Androgenetic Alopecia Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).

The US market dominated the North America Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,143.2 Million by 2030. The Canada market is experiencing a CAGR of 9.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.3% during (2023 - 2030).

One of the primary drivers of adoption in the androgenetic alopecia market is the growing awareness and acceptance of hair loss as a common condition. As public understanding of androgenetic alopecia expands, more individuals seek information and solutions to address their concerns. This increased awareness has led to a shift in societal attitudes, with a greater acceptance of seeking medical or cosmetic interventions for hair loss. A decreasing stigma is associated with seeking cosmetic enhancements for both men and women. As societal norms change, individuals are more open to exploring various interventions to address their hair loss concerns, contributing to the overall adoption of treatments within the market.

Media and social media platforms are crucial in shaping beauty standards and influencing individual choices. Celebrity endorsements and testimonials regarding hair restoration treatments have become common, impacting the adoption rates within the market. High-profile figures openly discussing their experiences with hair loss treatments contribute to the normalization of seeking such interventions. Individuals from diverse locations can access information about different treatment options, connect with specialists, and choose interventions that suit their preferences and needs.

As per the International Trade Administration (ITA), in the first half of 2022, the Canadian cosmetics industry was the fastest-growing industry in the country. In 2022, Canada’s personal care and beauty sector earned around $11 billion in revenue. Advancements in technology, such as laser therapy, platelet-rich plasma (PRP) treatments, and robotic hair transplantation, are gaining popularity in Canada. Celebrity endorsements, media representation, and the influence of social media contribute to shaping beauty standards and aesthetic preferences in Canada. Also, ITA estimates by 2024, cosmetic industry revenue is anticipated to increase by 1.45% yearly to USD 1.8 billion. Hence, the factors mentioned above will drive the regional market growth.

Free Valuable Insights: The Androgenetic Alopecia Market is Predict to reach USD 4.6 Billion by 2030, at a CAGR of 8.1%

Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Cipla Limited
• Merck & Co., Inc.
• GlaxoSmithKline PLC (GSK)
• Sun Pharmaceuticals Industries Ltd.
• Dr.Reddy’s Laboratories Ltd.
• Aurobindo Pharma Limited
• Pfizer, Inc.
• Lutronic Co., Ltd.
• Viatris Inc.
• Eli Lilly and Company

North America Androgenetic Alopecia Market Report Segmentation

By Treatment

• Pharmaceuticals
• Devices

By Gender

• Male
• Female

By Sales Channel

• Prescriptions
• OTC

By End-use

• Dermatology Clinics
• Homecare Settings

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Androgenetic Alopecia Market, by Treatment
1.4.2 North America Androgenetic Alopecia Market, by Gender
1.4.3 North America Androgenetic Alopecia Market, by Sales Channel
1.4.4 North America Androgenetic Alopecia Market, by End-use
1.4.5 North America Androgenetic Alopecia Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Androgenetic Alopecia Market, By Treatment
4.1 North America Pharmaceuticals Market, By Country
4.2 North America Devices Market, By Country

Chapter 5. North America Androgenetic Alopecia Market, By Gender
5.1 North America Male Market, By Country
5.2 North America Female Market, By Country

Chapter 6. North America Androgenetic Alopecia Market, By Sales Channel
6.1 North America Prescriptions Market, By Country
6.2 North America OTC Market, By Country

Chapter 7. North America Androgenetic Alopecia Market, By End-use
7.1 North America Dermatology Clinics Market, By Country
7.2 North America Homecare Settings Market, By Country

Chapter 8. North America Androgenetic Alopecia Market, By Country
8.1 US Androgenetic Alopecia Market
8.1.1 US Androgenetic Alopecia Market, By Treatment
8.1.2 US Androgenetic Alopecia Market, By Gender
8.1.3 US Androgenetic Alopecia Market, By Sales Channel
8.1.4 US Androgenetic Alopecia Market, By End-use
8.2 Canada Androgenetic Alopecia Market
8.2.1 Canada Androgenetic Alopecia Market, By Treatment
8.2.2 Canada Androgenetic Alopecia Market, By Gender
8.2.3 Canada Androgenetic Alopecia Market, By Sales Channel
8.2.4 Canada Androgenetic Alopecia Market, By End-use
8.3 Mexico Androgenetic Alopecia Market
8.3.1 Mexico Androgenetic Alopecia Market, By Treatment
8.3.2 Mexico Androgenetic Alopecia Market, By Gender
8.3.3 Mexico Androgenetic Alopecia Market, By Sales Channel
8.3.4 Mexico Androgenetic Alopecia Market, By End-use
8.4 Rest of North America Androgenetic Alopecia Market
8.4.1 Rest of North America Androgenetic Alopecia Market, By Treatment
8.4.2 Rest of North America Androgenetic Alopecia Market, By Gender
8.4.3 Rest of North America Androgenetic Alopecia Market, By Sales Channel
8.4.4 Rest of North America Androgenetic Alopecia Market, By End-use

Chapter 9. Company Profiles
9.1 Cipla Limited
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Merck & Co., Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 GlaxoSmithKline PLC (GSK)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Sun Pharmaceuticals Industries Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Dr. Reddy’s Laboratories Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 Aurobindo Pharma Limited
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Trails and Approvals:
9.7.6 SWOT Analysis
9.8 Lutronic Co., Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Viatris, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Eli Lilly And Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

TABLE 1 North America Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 2 North America Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 3 North America Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 4 North America Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 5 North America Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
TABLE 6 North America Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
TABLE 7 North America Devices Market, By Country, 2019 - 2022, USD Million
TABLE 8 North America Devices Market, By Country, 2023 - 2030, USD Million
TABLE 9 North America Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 10 North America Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 11 North America Male Market, By Country, 2019 - 2022, USD Million
TABLE 12 North America Male Market, By Country, 2023 - 2030, USD Million
TABLE 13 North America Female Market, By Country, 2019 - 2022, USD Million
TABLE 14 North America Female Market, By Country, 2023 - 2030, USD Million
TABLE 15 North America Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 16 North America Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 17 North America Prescriptions Market, By Country, 2019 - 2022, USD Million
TABLE 18 North America Prescriptions Market, By Country, 2023 - 2030, USD Million
TABLE 19 North America OTC Market, By Country, 2019 - 2022, USD Million
TABLE 20 North America OTC Market, By Country, 2023 - 2030, USD Million
TABLE 21 North America Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 22 North America Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 23 North America Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
TABLE 24 North America Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
TABLE 25 North America Homecare Settings Market, By Country, 2019 - 2022, USD Million
TABLE 26 North America Homecare Settings Market, By Country, 2023 - 2030, USD Million
TABLE 27 North America Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
TABLE 28 North America Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
TABLE 29 US Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 30 US Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 31 US Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 32 US Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 33 US Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 34 US Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 35 US Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 36 US Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 37 US Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 38 US Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 39 Canada Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 40 Canada Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 41 Canada Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 42 Canada Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 43 Canada Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 44 Canada Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 45 Canada Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 46 Canada Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 47 Canada Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 48 Canada Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 49 Mexico Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 50 Mexico Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 51 Mexico Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 52 Mexico Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 53 Mexico Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 54 Mexico Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 55 Mexico Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 56 Mexico Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 57 Mexico Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 58 Mexico Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 59 Rest of North America Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 60 Rest of North America Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 61 Rest of North America Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 62 Rest of North America Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 63 Rest of North America Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 64 Rest of North America Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 65 Rest of North America Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 66 Rest of North America Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 67 Rest of North America Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 68 Rest of North America Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 69 Key Information – Cipla Limited
TABLE 70 Key Information - Merck & Co., Inc.
TABLE 71 Key Information – GlaxoSmithKline PLC
TABLE 72 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 73 Key Information – Dr. Reddy’s Laboratories Ltd.
TABLE 74 key information – Aurobindo Pharma Limited
TABLE 75 Key Information – Pfizer, Inc.
TABLE 76 Key Information – lUTRONIC cO., lTD.
TABLE 77 key information – Viatris, Inc.
TABLE 78 Key Information – Eli Lilly And Company

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Androgenetic Alopecia Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Androgenetic Alopecia Market
FIG 4 Porter’s Five Forces Analysis – Androgenetic Alopecia Market
FIG 5 North America Androgenetic Alopecia Market share, By Treatment, 2022
FIG 6 North America Androgenetic Alopecia Market share, By Treatment, 2030
FIG 7 North America Androgenetic Alopecia Market, By Treatment, 2019 - 2030, USD Million
FIG 8 North America Androgenetic Alopecia Market share, By Gender, 2022
FIG 9 North America Androgenetic Alopecia Market share, By Gender, 2030
FIG 10 North America Androgenetic Alopecia Market, By Gender, 2019 - 2030, USD Million
FIG 11 North America Androgenetic Alopecia Market share, By Sales Channel, 2022
FIG 12 North America Androgenetic Alopecia Market share, By Sales Channel, 2030
FIG 13 North America Androgenetic Alopecia Market, By Sales Channel, 2019 - 2030, USD Million
FIG 14 North America Androgenetic Alopecia Market share, By End-use, 2022
FIG 15 North America Androgenetic Alopecia Market share, By End-use, 2030
FIG 16 North America Androgenetic Alopecia Market, By End-use, 2019 - 2030, USD Million
FIG 17 North America Androgenetic Alopecia Market share, By Country, 2022
FIG 18 North America Androgenetic Alopecia Market share, By Country, 2030
FIG 19 North America Androgenetic Alopecia Market, By Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Cipla Limited
FIG 21 SWOT Analysis: Merck & Co., Inc.
FIG 22 SWOT Analysis: GlaxoSmithKline PLC
FIG 23 SWOT Analysis: Sun Pharmaceuticals Industries Ltd.
FIG 24 SWOT Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 25 SWOT Analysis: Aurobindo Pharma Limited
FIG 26 SWOT Analysis: Pfizer, Inc.
FIG 27 SWOT Analysis: Lutronic Co., Ltd.
FIG 28 SWOT Analysis: Viatris, Inc.
FIG 29 Swot Analysis: Eli Lilly And Company